Ekso Bionics Holdings, Inc. logo

Ekso Bionics Holdings, Inc. (EKSO)

Market Closed
15 May, 20:00
NASDAQ (CM) NASDAQ (CM)
$
11. 80
+0.15
+1.29%
$
28.63M Market Cap
- P/E Ratio
- Div Yield
95,135 Volume
-1.29 Eps
$ 11.65
Previous Close
Add Transaction
Day Range
11.4 11.8
Year Range
2.73 13.5
Want to track EKSO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

EKSO closed Friday higher at $11.8, an increase of 1.29% from Thursday's close, completing a monthly decrease of -3.75% or -$0.46. Over the past 12 months, EKSO stock gained 38.01%.
EKSO is not paying dividends to its shareholders.
The last earnings report, released on May 04, 2026, exceeded the consensus estimates by 0.03%. On average, the company has surpassed earnings expectations by 0.37%, based on the last three reports.
Ekso Bionics Holdings, Inc. has completed 5 stock splits, with the recent split occurring on Jun 02, 2025.
The company's stock is traded on one exchange.

EKSO Chart

People also search for

SuperCom Ltd.
$ 11.09
-7.2%
Fingermotion Inc.
$ 0.9
+29.48%
Viewbix Inc.
$ 4.77
0%
Santech Holdings Ltd. Depositary Receipt
$ 1.53
-87.86%
CCG
Cheche Group Inc.
$ 0.5
-7.56%
Applied Digital And The EKSO Transaction: Buy This Clear Story

Applied Digital And The EKSO Transaction: Buy This Clear Story

Applied Digital Corporation is moving from a mixed and hard-to-value structure into two focused businesses with clearer roles, funding paths and investor bases. The cloud separation creates a pure AI infrastructure vehicle while allowing the parent to remain a stable, contract-driven infrastructure operator. The APLD transaction reshapes the valuation logic by separating stable cash flow assets from higher growth but higher risk computing assets.

Seekingalpha | 5 months ago
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Ekso Bionics (EKSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 6 months ago
Ekso Bionics (EKSO) Reports Q3 Loss, Beats Revenue Estimates

Ekso Bionics (EKSO) Reports Q3 Loss, Beats Revenue Estimates

Ekso Bionics (EKSO) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.99. This compares to a loss of $1.5 per share a year ago.

Zacks | 7 months ago

Ekso Bionics Holdings, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
CM
Carmen McClennon WR Wealth Planners, LLC
1.94 $39 $22.93 -$16.07 -41.21%
MO
Matthew Okkerse Dauntless Investment Group LLC
35,493 $378,000 $418,817.4 $40,817.4 10.8%
WM
William Mueller Mink Brook Asset Management LLC
95,331 $1.02M $1.12M $109,630.8 10.8%
RPA
Redwood Park Advisors LLC Redwood Park Advisors LLC
2 $18 $23.6 $5.6 31.11%

Ekso Bionics Holdings, Inc. (EKSO) FAQ

What is the stock price today?

The current price is $11.80.

On which exchange is it traded?

Ekso Bionics Holdings, Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is EKSO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 28.63M.

Has Ekso Bionics Holdings, Inc. ever had a stock split?

Ekso Bionics Holdings, Inc. had 5 splits and the recent split was on Jun 02, 2025.

Ekso Bionics Holdings, Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Scott G. Davis CEO
NASDAQ (CM) Exchange
282644400 CUSIP
US Country
61 Employees
25 Mar 2020 Last Dividend
2 Jun 2025 Last Split
16 Jan 2014 IPO Date

Overview

Ekso Bionics Holdings, Inc. is a pioneer in the field of robotic exoskeletons, focusing on designing, developing, selling, and renting a range of exoskeleton products globally. With its operations spanning across the Americas, Germany, Poland, Europe, the Middle East, Africa, and the Asia Pacific, the company caters to both medical and industrial sectors through its two primary segments: EksoHealth and EksoWorks. The EksoHealth segment is dedicated to the medical market, providing innovative solutions for individuals with neurological or physical disabilities, while the EksoWorks segment targets the industrial domain, offering devices that enhance the productivity and safety of able-bodied users performing strenuous repetitive tasks. Founded in 2005 and headquartered in San Rafael, California, Ekso Bionics is at the forefront of wearable bionic technology, aiming to improve human mobility and efficiency through their groundbreaking products.

Products and Services

  • EksoNR
  • A cutting-edge wearable bionic suit and rehabilitation device, the EksoNR is designed to assist physical therapists and physicians in the treatment of patients suffering from acquired brain injury, stroke, and spinal cord injury. Its primary aim is to facilitate and enhance mobility and strength during the rehabilitation process, thereby accelerating patient recovery.

  • Ekso Indego Therapy
  • This adjustable, powered lower-limb exoskeleton is tailored for use in therapy settings. The Ekso Indego Therapy exoskeleton provides support and mobility for individuals undergoing rehabilitation, focusing on improving gait and independence in users with mobility impairments.

  • Ekso Indego Personal
  • As a personal use version of the therapy exoskeleton, the Ekso Indego Personal offers individuals with lower limb paralysis or weakness the opportunity to stand and walk at home and in their communities. It represents a significant step towards personal mobility and independence for individuals with mobility challenges.

  • Ekso Nomad
  • The Ekso Nomad is a power knee ankle foot orthosis designed to offer dynamic support for individuals requiring assistance with lower-limb mobility. It integrates seamlessly into the user’s life, providing a more natural gait pattern and empowering users in their daily activities.

  • Ekso EV
  • Targeting the industrial sector, the Ekso EV is a wearable upper body exoskeleton that supports and elevates a worker's arms for tasks ranging from chest height to overhead positions. This device is engineered to reduce the physical strain on workers performing repetitive tasks and thus, mitigating the risk of work-related injuries while increasing productivity.

Contact Information

Address: 1414 Harbour Way South
Phone: 510 984 1761